Articles about COVID-19 Vaccine

Confirming its first COVID-19 case on Thursday, North Korea ordered a nationwide lockdown calling it the "gravest national emergency."

India on Wednesday reported nearly 3,000 new COVID-19 cases, an increase of over 500 cases from the previous day.

In a significant move, the Drugs Controller General of India (DCGI) on Tuesday cleared two COVID-19 vaccines for use in children aged between five and 12 years.

The Modi government is considering making COVID-19 booster vaccine doses available to all adults, a Reuters report claimed, citing sources aware of the matter.

India on Wednesday started vaccination of children aged 12 to 14 years as it expands its COVID-19 vaccination coverage.

In a major boost to India's COVID-19 vaccination efforts, India will start administering the vaccine against the novel coronavirus to children aged between 12 and 14 years from Wednesday.

Vaxart, a United States-based biotechnology company, is set to begin the second phase of clinical trial for its oral COVID-19 vaccine in India, according to a report by News18.

The Centre on Wednesday ruled out the mixing up of COVID-19 vaccines for the third "precautionary" dose.

A day before India widens its COVID-19 vaccination drive to include teenagers aged 15-18 years, over five lakh such beneficiaries registered themselves to be inoculated.

Gurugram has become the first district in Haryana to administer both doses of COVID-19 vaccines to all eligible civilians, the health department announced Tuesday.

The Serum Institute of India is looking to launch a COVID-19 vaccine for children in six months, SII CEO Adar Poonawalla said Tuesday.

Seven COVID-19 vaccines are safe and stimulate a strong immune response when used as a booster jab to those who have already vaccinated, a study published in The Lancet said.

India on Thursday reported over 9,000 new COVID-19 cases with an active caseload of just under one lakh.

The COVID-19 vaccine manufacturers in India are reportedly waiting for "more data" on the new coronavirus variant, Omicron, to assess the efficacy of their vaccines.

India's COVID-19 task force chief Dr. NK Arora said a comprehensive policy on the booster and additional COVID-19 vaccine jabs will be announced in two weeks.

India on Monday reported over 8,000 new COVID-19 cases, the lowest single-day tally in the last 538 days.

India exported over 65 million COVID-19 vaccine doses to nearly 100 countries this year, said Prime Minister Narendra Modi on Thursday.

India on Tuesday reported nearly 9,000 new COVID-19 cases, which is the lowest daily tally in the last nine months.

India on Monday reported over 10,000 new COVID-19 cases with an active caseload of 1.34 lakh, the lowest in 523 days.

Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine Corbevex's samples were cleared by the Central Drugs Laboratory in Kasauli on Tuesday.

Most COVID-19 cases reported in Kerala over the past two weeks involved breakthrough infections, official data showed.

India on Wednesday reported nearly 12,000 new COVID-19 cases with an active caseload of 1.51 lakh, the lowest in 252 days.

American firm Johnson & Johnson's COVID-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are ready for export, News18 reported.

The Union Health Ministry will convene a meeting on November 3 to boost the COVID-19 vaccination capacity of 11 states, whose numbers are lagging behind the national average.

India on Sunday reported over 15,000 new COVID-19 cases with an active caseload of 1.72 lakh, the lowest in 235 days.

India on Friday reported over 15,000 new COVID-19 cases with an active caseload of 1.75 lakh, the lowest in 232 days.

India's top virologist Dr. Gagandeep Kang has said that there should not be any hurry to vaccinate children against COVID-19 as vaccine trials are ongoing and immunogenicity data is still awaited.

The Subject Expert Committee (SEC) on COVID-19 has recommended the approval of Bharat Biotech's COVAXIN for children aged between two and 18 years.

The United Kingdom has announced that Indians who are fully vaccinated with Covishield or any other UK-approved coronavirus vaccine will not have to quarantine upon arrival in Britain from Monday, October 11.

COVID-19 vaccine hesitancy among adult Indians has reduced to 7% of the total population, the lowest among Indians since January 2021, a survey has found.

COVAXIN, India's indigenous vaccine against the coronavirus, will likely receive the much-awaited approval from the World Health Organization (WHO) this month.

Union Health Minister Mansukh Mandaviya said on Monday that 70% of India's eligible adult population has been administered at least one COVID-19 vaccine dose.

The indigenous COVID-19 vaccine developed by Zydus Cadila, called ZyCoV-D, is likely to be rolled out in the next two weeks.

With the emergence of new coronavirus variants and talk of waning immunity of COVID-19 vaccines, discussions have been on about whether booster doses are required for the general public.

Prime Minister Narendra Modi attended the first in-person meeting of Quad (Quadrilateral Security Dialogue) leaders in Washington on Friday, hosted by United States President Joe Biden.

The central government on Thursday announced COVID-19 vaccinations at home for people who cannot reach vaccination centers due to restricted mobility or disabilities.

On the issue of the non-recognition of India's COVID-19 vaccine certification, the United Kingdom has maintained that the vaccine certificates of all countries must meet the minimum criteria.

As economic activities have mostly resumed across the country, state governments are putting all efforts to ensure people get their second dose of the COVID-19 vaccine.

The United Kingdom on Wednesday revised its travel advisory, listing Covishield as an approved COVID-19 vaccine.

World Health Organization Director-General Tedros Adhanom Ghebreyesus has hailed India's decision to resume COVID-19 vaccine exports as an important development in support of the goal to reach 40% vaccination in all countries by end of the year.